Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The company has entered into a three-year Deferred Prosecution Agreement
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
According to IQVIA sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 mg and 10 mg market achieved annual sales of approximately US $26.9 million
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)